Valuation: Valbiotis

Market Cap 22.29M 24.89M 20.5M 18.58M 34.72M 2.36B 35.37M 244M 98.15M 1.24B 93.4M 91.41M 3.92B P/E 2026 *
-2.51x
P/E 2027 * -3.49x
Enterprise Value 28.49M 31.81M 26.21M 23.74M 44.38M 3.02B 45.21M 313M 125M 1.59B 119M 117M 5.01B EV / Sales 2026 *
14.2x
EV / Sales 2027 * 5.66x
Free-Float
97.31%
Yield 2026 *
-
Yield 2027 * -
1 day-3.24%
1 week+13.56%
Current month-8.99%
1 month-11.55%
3 months-17.37%
6 months-32.55%
Current year-9.51%
1 week 0.55
Extreme 0.554
0.67
1 month 0.49
Extreme 0.486
0.69
Current year 0.49
Extreme 0.486
1.3
1 year 0.49
Extreme 0.486
1.3
3 years 0.49
Extreme 0.486
7.34
5 years 0.49
Extreme 0.486
7.5
10 years 0.49
Extreme 0.486
10.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2024-02-29
Chief Tech/Sci/R&D Officer - 2017-08-31
Director TitleAgeSince
Chairman 55 2017-02-28
Director/Board Member - 2017-10-25
Director/Board Member - 2019-03-17
Date Insider Type Main position Quantity % Market Cap. Importance
1/28/22 Others

Founder

42,480 0.4364%
1/28/22 Exercice

Founder

2,095 0.0215%
7/10/21 Exercice

Chief Technology Officer

2,000 0.0206%
Change 5-day change 1-year change 3-year change Capi.($)
-3.24%+13.56%-15.14%-88.90% 25.72M
-0.62%+0.50%+33.92%+60.07% 64.38B
+0.35%+3.04%+12.64%+83.62% 56.16B
+0.53%+2.55%+13.90%+104.77% 54.16B
-2.81%-3.95%+22.72%+48.57% 45.33B
-0.33%-3.12%+17.62%+117.27% 42.25B
+0.55%+1.93%+229.73%+928.00% 40.78B
+3.27%+47.40%+110.44%+94.92% 33.8B
+1.22%-1.39%+13.92%+46.95% 32.25B
-1.29%-1.72%+21.00%-6.85% 23.57B
Average -0.25%+5.98%+46.08%+138.84% 39.27B
Weighted average by Cap. +0.01%+3.64%+49.57%+162.46%

Financials

2026 *2027 *
Net sales 2M 2.23M 1.84M 1.67M 3.12M 212M 3.17M 21.94M 8.81M 112M 8.38M 8.2M 352M 6.5M 7.26M 5.98M 5.42M 10.13M 689M 10.32M 71.3M 28.62M 362M 27.24M 26.66M 1.14B
Net income -8.8M -9.83M -8.09M -7.33M -13.71M -933M -13.97M -96.53M -38.75M -491M -36.88M -36.09M -1.55B -6.5M -7.26M -5.98M -5.42M -10.13M -689M -10.32M -71.3M -28.62M -362M -27.24M -26.66M -1.14B
Net Debt 6.2M 6.92M 5.7M 5.17M 9.66M 657M 9.84M 68.01M 27.3M 346M 25.98M 25.43M 1.09B 14.5M 16.19M 13.34M 12.09M 22.59M 1.54B 23.01M 159M 63.85M 809M 60.76M 59.47M 2.55B
Projected Income Statement - Annual - Valbiotis
Logo Valbiotis
VALBIOTIS is a French laboratory specializing in the creation and distribution of dietary supplements scientifically tested to maintain health at every stage of life. Through an innovative approach combining scientific excellence, plant expertise and a wealth of natural ingredients, VALBIOTIS offers a new generation of dietary supplements to support cardio-metabolic balance and well-being, and address everyday health issues such as sleep, fatigue, mood management, immunity and vitality.
Employees
50
Date Price Change Volume
26-10-30 €0.6280 -3.24% 83,346
26-10-29 €0.6490 +3.67% 124,431
26-10-28 €0.6260 +4.51% 103,430
26-10-27 €0.5990 +6.96% 118,344
26-10-26 €0.5600 +0.90% 40,869
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Valbiotis
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.6280EUR
Average target price
1.350EUR
Spread / Average Target
+114.97%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Valbiotis
  1. Stock Market
  2. Stocks
  3. ALVAL Stock